Lyell Immunopharma, Inc. Annual Depreciation, Depletion and Amortization in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Lyell Immunopharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2019 to 2023.
  • Lyell Immunopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $5.02M, a 0.06% decline year-over-year.
  • Lyell Immunopharma, Inc. annual Depreciation, Depletion and Amortization for 2023 was $20.3M, a 12.4% increase from 2022.
  • Lyell Immunopharma, Inc. annual Depreciation, Depletion and Amortization for 2022 was $18M, a 32.3% increase from 2021.
  • Lyell Immunopharma, Inc. annual Depreciation, Depletion and Amortization for 2021 was $13.6M, a 217% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.